Published in Am J Cardiol on May 15, 1998
Left Atrial Appendage Function and Stroke Risk. Stroke (2015) 0.80
Mitral annular velocity by Doppler tissue imaging for the evaluation of atrial stunning after cardioversion of atrial fibrillation. Int J Cardiovasc Imaging (2008) 0.78
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med (1995) 4.37
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04
The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med (1991) 3.17
Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 2.62
Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice. Heart (2008) 2.13
Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation (2000) 2.12
Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med (1986) 2.00
Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med (1989) 1.96
Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart (1997) 1.72
Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest (1994) 1.69
Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol (1986) 1.59
A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res (1998) 1.59
Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann Oncol (2009) 1.57
Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol (1987) 1.57
Myocardial contusion after a professional boxing match. Am J Cardiol (1992) 1.56
Quantitative assessment of ultrasonic myocardial reflectivity in hypertrophic cardiomyopathy. J Am Coll Cardiol (1991) 1.53
Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol (1994) 1.52
Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1987) 1.46
Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation (1995) 1.39
Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study. Am J Cardiol (1998) 1.31
Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major. Circulation (1990) 1.24
Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol (1983) 1.22
Spontaneous morphologic changes in left ventricular thrombi: a prospective two-dimensional echocardiographic study. Circulation (1987) 1.19
Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing "athlete's heart" from hypertrophic cardiomyopathy. Br Heart J (1992) 1.15
Acidic fibroblast growth factor in the developing rat embryo. J Cell Biol (1991) 1.15
Left ventricular thrombus in anterior acute myocardial infarction after thrombolysis. A GISSI-2 connected study. Circulation (1991) 1.06
Quantitative ultrasonic analysis of myocardium in patients with thalassemia major and iron overload. Circulation (1993) 1.05
Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study. Circulation (1985) 1.02
A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy. Circulation (1995) 1.01
Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol (1998) 1.00
Influence of formulation and process parameters on pellet production by powder layering technique. AAPS PharmSciTech (2000) 0.99
Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol (1997) 0.99
Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol (1993) 0.98
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathol Appl Neurobiol (2004) 0.97
Noninvasive assessment of left ventricular diastolic function: comparative analysis of pulsed Doppler ultrasound and digitized M-mode echocardiography. Am J Cardiol (1986) 0.95
Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol (1986) 0.95
Long-term prospective assessment of left ventricular thrombus in anterior wall acute myocardial infarction and implications for a rational approach to embolic risk. Am J Cardiol (1999) 0.94
The use of beta-cyclodextrin as a pelletization agent in the extrusion/spheronization process. Drug Dev Ind Pharm (1998) 0.93
Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply. J Neurooncol (2002) 0.93
Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1987) 0.93
Non-pharmacological approaches to chronic headaches: transcutaneous electrical nerve stimulation, lasertherapy and acupuncture in transformed migraine treatment. Neurol Sci (2003) 0.89
Familial supravalvular aortic stenosis: a genetic study. J Med Genet (1989) 0.89
Panoramic coronary angiography. J Am Coll Cardiol (1998) 0.87
The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases. Eur J Surg Oncol (2005) 0.87
Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and type 2 diabetes. Eur J Nutr (2010) 0.86
Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy. Circulation (1985) 0.86
Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy. Anatomic validation from mitral valve specimen. Circulation (1993) 0.84
Early appearance of left ventricular thrombi after anterior myocardial infarction: a marker of higher in-hospital mortality in patients not treated with antithrombotic drugs. Eur Heart J (1990) 0.84
The relation between supraventricular tachyarrhythmias and left ventricular dysfunction after acute myocardial infarction. Acta Cardiol (1988) 0.84
Oxytocin receptor in human fetal membranes at term and during labor. J Steroid Biochem (1990) 0.84
The exercise test in variant angina: results in 114 patients. Circulation (1981) 0.84
Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery. Semin Surg Oncol (1998) 0.83
Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes. Eur J Surg Oncol (2011) 0.83
Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a two-dimensional echocardiographic assessment. Circulation (1983) 0.83
Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol (1998) 0.83
Pre-operative localization of non-palpable lesions in breast cancer by charcoal suspension. Eur J Surg Oncol (1995) 0.82
Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy. Circulation (1983) 0.82
Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment. Circulation (1984) 0.82
[Ultrasound in diagnosis of superior mesenteric artery syndrome]. Clin Ter (2010) 0.82
Penetrating brain injuries from a dog bite in an infant. Pediatr Neurosurg (2005) 0.82
Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value. Eur Heart J (1994) 0.82
Early echocardiographic detection of right-sided intracardiac thrombus. Int J Cardiol (1986) 0.81
Exercise-induced RS-T elevation. Electrocardiographic and angiographic observations. Cardiology (1972) 0.81
Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson (2010) 0.81
Sudden death and hypertrophic cardiomyopathy. Lancet (2001) 0.80
Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients. J Surg Oncol (2000) 0.80
Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients. Int J Oncol (2000) 0.80
Intracranial hemorrhage associated with vitamin K deficiency in a breastfed infant after intramuscular vitamin K prophylaxis at birth. follow-up at 18 months. Acta Paediatr (2000) 0.80
Hypertrophic cardiomyopathy. JAMA (1999) 0.79
Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients. J Surg Oncol (2001) 0.79
Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction. Am J Cardiol (1996) 0.78
Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment by two-dimensional echocardiography. Am J Cardiol (1984) 0.78
Influence of thrombolytic treatment followed by full dose anticoagulation on the frequency of left ventricular thrombi in acute myocardial infarction. Am J Cardiol (1989) 0.78
Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial. Eur J Surg Oncol (1997) 0.78
[Early functional evaluation and physical rehabilitation in patients with wide myocardial infarction (author's transl)]. G Ital Cardiol (1981) 0.78
Cardiac involvement in thalassaemia major: altered atrial natriuretic peptide levels in asymptomatic patients. Eur Heart J (1992) 0.78
Changes in effective aortic valve area during ejection in adults with aortic stenosis. Am J Cardiol (1996) 0.78
[Osteomalacia and antiepileptic drugs: study on the pathogenesis]. Schweiz Med Wochenschr (1975) 0.78
Telomerase in intracranial meningiomas. Int J Mol Med (2003) 0.78
Coronarographic patterns in Prinzmetal's variant angina. Acta Cardiol (1971) 0.78
Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy. Am J Cardiol (1992) 0.78
Clinical significance of supraventricular tachyarrhythmias after acute myocardial infarction. Eur Heart J (1986) 0.77
Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: always or never? A risk/benefit and cost/benefit analysis. Eur J Surg Oncol (2010) 0.77
Hearing loss etiology in a group of 996 children. Ann N Y Acad Sci (1991) 0.77
Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue-dye, and intraoperative gamma-probe. Cancer Biother Radiopharm (2000) 0.77
[Echocardiographic and anatomic evaluation of left ventricular thrombosis]. G Ital Cardiol (1987) 0.77
Hearing threshold assessment with auditory brainstem response (ABR) and ElectroCochleoGraphy (ECochG) in uncooperative children. Scand Audiol Suppl (1997) 0.77